Artwork for Journal of Clinical Oncology (JCO) Podcast

Journal of Clinical Oncology (JCO) Podcast · May 31 · 8 min

JCO at ASCO 2026: Neoadjuvant Sacituzumab in MIBC

JCO Editorial Fellow Dr. Jake New and JCO Associate Editor Dr. Umang Swami discuss the ASCO 2026 Simultaneous Publication paper "Neoadjuvant Sacituzumab Govitecan in Patients with Muscle-Invasive Bladder Cancer: Primary Results of SURE-01 Trial." LINK TO FULL TRANSCRIPT

0:00-8:56

Play in

transcript

No transcript — this publisher did not publish one.

show notes

JCO Editorial Fellow Dr. Jake New and JCO Associate Editor Dr. Umang Swami discuss the ASCO 2026 Simultaneous Publication paper "Neoadjuvant Sacituzumab Govitecan in Patients with Muscle-Invasive Bladder Cancer: Primary Results of SURE-01 Trial."

LINK TO FULL TRANSCRIPT

links2

more episodes

Bladder Adjuvant RadioTherapy (BART) RCT for High Risk MIBC
August 13 · 17 min
JCO Article Insights: Duvelisib in Patients with Relapsed or Refractory PTCL
July 27 · 11 min
Effectiveness of a Virtual Tobacco Treatment for Cancer Patients
July 16 · 24 min
Phase 2 Study of Multi-Cancer Detection from Breath Samples
June 11 · 20 min
JCO at ASCO 2026: Individualized Neoantigen Therapy Plus Pembrolizumab in Melanoma
June 1 · 10 min
JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma
June 1 · 12 min

All episodes